# Deferoxamine mesylate

NDC: 60505-6237
Generic name: Deferoxamine mesylate
Labeler / Manufacturer: Apotex Corp.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20211105

FDA application: ANDA207384

## Active ingredients

- DEFEROXAMINE MESYLATE: 2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-6237"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-6237
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c99553fb-3fae-b88a-6c2c-efa7520197f9